
Revenue
$206.48M
2024
Valuation
$4.16B
2024
Growth Rate (y/y)
162%
2024
Funding
$1.12B
2024
Revenue
Sacra estimates Cerebras will reach $272M in revenue for 2024, based on their H1'24 revenue of $136.4M, representing approximately 245% year-over-year growth.
The company maintains significant customer concentration with their primary enterprise client G42, which accounts for 87% of revenue, stemming from a strategic partnership that includes a commitment to purchase $1.43B of computing systems and services.
Cerebras' revenue model centers on their hardware and software offerings: sales of their wafer-scale chip systems, their CSoft software platform, and associated services. Their AI supercomputer systems command premium pricing due to superior performance claims, including 10x faster training time-to-solution and over 10x faster output generation speeds compared to GPU-based alternatives.
The company's gross margins have shown improvement from 11.7% in 2022 to 33.5% in 2023, though they experienced some compression in early 2024 (41.1%) due to volume-based discounts offered to G42.
Valuation
Based on their 2021 valuation of $4.1B, Cerebras was valued at a multiple of 341x on roughly $12.5M of revenue. The company raised over $770M in total funding across multiple rounds. Key investors include Benchmark and Foundation Capital.
Product

Founded in 2016, Cerebras Systems is an AI hardware manufacturer and computing services provider, specializing in wafer-scale technology for artificial intelligence workloads. The company's flagship product is the CS-3 system, powered by the Wafer Scale Engine 3 (WSE-3). The WSE-3 is the largest and fastest chip ever created, measuring 46,000 square millimeters (about the size of a dinner plate) and built on TSMC's 5nm process.
Traditional AI chips, like those from NVIDIA or Groq, are typically the size of a postage stamp and are clustered together to achieve high performance. In contrast, the WSE-3's design offers a few critical advantages for AI workloads:
Data Locality: By keeping all computations on a single, large chip, Cerebras dramatically reduces the need for data movement. In traditional GPU clusters, data must constantly move between chips, consuming time and energy. The WSE-3 keeps data local, resulting in significantly faster processing and lower power consumption.
Memory Bandwidth: The WSE-3 has vast on-chip memory with unprecedented bandwidth. This allows for faster data access and reduces bottlenecks commonly experienced in distributed GPU systems.
Simplified Scaling: While GPU clusters require complex software to distribute workloads across multiple chips, Cerebras's single-chip approach simplifies this process. This makes it easier to scale up to larger AI models without the overhead of managing distributed computing resources.
These advantages make Cerebras systems particularly well-suited for training large AI models and handling complex, data-intensive workloads. For instance, training a 175 billion parameter model on 4,000 GPUs might require 20,000 lines of code for distribution, while Cerebras can accomplish this with just 565 lines of code in one day.
Product-market fit
Overall, Cerebras positions itself for customers who have outgrown smaller-scale AI solutions and need supercomputer-level performance. Their systems are designed for organizations training large models or working with vast datasets, typically those spending millions on AI compute annually. In addition to hardware, Cerebras offers professional services, including assistance with data preparation, model design, training oversight, and optimization. This service component accounts for between a quarter and a third of new customer engagements.
The company has found product-market fit across several sectors.
In the government and research space, Cerebras has run the table on supercomputer labs, including Argonne National Laboratory, Lawrence Livermore National Laboratory, and Sandia National Laboratory, among others. Governments worldwide are also investing in Cerebras technology for sovereign clouds to meet domestic AI requirements.
In the private sector, Cerebras serves customers in pharmaceuticals and life sciences, such as GlaxoSmithKline, which uses the technology for pioneering work in epigenomics, while Mayo Clinic is using Cerebras systems to enhance medical diagnostics and personalized medicine.
In the energy sector, TotalEnergies, a $100 billion French company, is a notable customer. While not specifically named, Cerebras also works with companies in the finance space on complex modeling and risk assessment.